Related Experiment Video
Updated: Jan 9, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
"Objective sleep apnea severity, cognitive impairment and AD pathology: Insights from the ALBION cohort"
Ioannis Foukarakis1, Xenia Androni1, Stefanos N Sampatakakis1
11st Department of Neurology, Aiginition Hospital, Medical School, National and Kapodistrian University of Athens, 11528, Athens, Greece.
Objectives:
Obstructive sleep apnea (OSA) appears to be closely related to cognitive status. This study explored the association between the Apnea-Hypopnea Index (AHI), cognitive status, and cerebrospinal fluid (CSF) biomarker pTau181/Aβ42 (AD pathology) in non-demented individuals.
Methods:
In this cross-sectional study, 115 non-demented participants from the ALBION cohort (mean age 64.4 ± 8.9 years, 70 % female, median education 14 years, median BMI 25.7 kg/m2) underwent a one-night WatchPAT evaluation to determine AHI (blood oxygen desaturation ≥3 %). Participants were categorized based on both cognitive status (patients with Mild Cognitive Impairment (MCI)[n = 27] or cognitively normal individuals (CN) [n = 88]) and AD pathology (AD+ [n = 25] or AD- [n = 90]). Binary logistic regression analysis, adjusted for age, sex, years of education, and BMI was used to assess the association of cognitive status and AD pathology with AHI. Participants were further divided into low (<15/h) and high (≥15/h) AHI levels and a joint analysis with AD pathology was performed with cognitive status as the outcome.
Results:
After adjusting for confounders, for each unit increase in AHI, the odds of being classified as MCI were 7 % higher (OR = 1.07, p = 0.003) and the odds of being classified as AD+ were 4 % higher (OR = 1.04, p = 0.043). Compared to the reference group [AD (-)/AHI(low)], the odds ratio of being classified as MCI was 4.48 (p = 0.022) in the AD (-)/AHI(high) and 15.30 (p = 0.0017) in the AD (+)/AHI(high) group.
Conclusions:
We find that higher AHI levels may contribute to cognitive impairment, either independently or alongside AD pathology. Further longitudinal studies are warranted to clarify causality and potential therapeutic benefits of OSA management on cognitive health.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
REM Sleep Behavior Disorder
RBD is significantly associated with...